We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OMGA market cap is 43.17M. The company's latest EPS is USD -1.7597 and P/E is -0.44.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 516k | 758k | 831k | 989k | 2.36M |
Operating Income | -25.82M | -30.84M | -22.9M | -20.88M | -20.45M |
Net Income | -25.28M | -29.69M | -22.25M | -20.21M | -20.13M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 144k | 2.07M | 3.09M |
Operating Income | -17.34M | -28.65M | -66.03M | -102.77M | -100.26M |
Net Income | -17.95M | -29.45M | -68.28M | -102.7M | -97.43M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 156.32M | 229.02M | 217.81M | 204.37M | 183.68M |
Total Liabilities | 33.32M | 133.1M | 141.77M | 146.35M | 142.33M |
Total Equity | 123M | 95.92M | 76.04M | 58.02M | 41.35M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 6.12M | 28.08M | 233.33M | 146M | 204.37M |
Total Liabilities | 15.33M | 17.49M | 32.71M | 40.03M | 146.35M |
Total Equity | -35.92M | -64.63M | 200.63M | 105.97M | 58.02M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -28.11M | -51.38M | -74.42M | -91.51M | -11.81M |
Investing | 22.05M | 46.1M | 45.38M | 47.52M | 4.47M |
Financing | 39.99M | 40.21M | 40.2M | 41.82M | -1.07M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -15.68M | -26.13M | -57.61M | -98.52M | -91.51M |
Investing | -885k | -1.81M | -40.4M | -18.06M | 47.52M |
Financing | 11.99M | 48.62M | 261.54M | 708k | 41.82M |
Market Cap | 43.17M |
Price to Earnings Ratio | -0.44 |
Price to Sales Ratio | 13.95 |
Price to Cash Ratio | 0.63 |
Price to Book Ratio | 0.74 |
Dividend Yield | - |
Shares Outstanding | 55.37M |
Average Volume (1 week) | 577.51k |
Average Volume (1 Month) | 342.08k |
52 Week Change | -58.96% |
52 Week High | 6.30 |
52 Week Low | 0.75 |
Spread (Intraday) | 0 (0.47%) |
Company Name | Omega Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.omegatherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions